The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Tester Jason E. since 2020.
The trader's CIK number is 1827272.
At the time of the last reporting, Tester Jason E. was the Director of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS).
Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TARS | 171,875 | $2,750,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-10-20 | TARS | Buy | 171,875 | 16.00 | 2,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tester Jason E. (Director of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.